These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7808141)

  • 21. How many doses of diphtheria toxoid are required for protection in adults? Results of a case-control study among 40- to 49-year-old adults in the Russian Federation.
    Brennan M; Vitek C; Strebel P; Wattigney W; Bisgard K; Brisgalov S; Bragina V; Pyanikh V; Wharton M
    J Infect Dis; 2000 Feb; 181 Suppl 1():S193-6. PubMed ID: 10657213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is diphtheria returning?].
    Rossi G
    Recenti Prog Med; 2000 Nov; 91(11):602-3. PubMed ID: 11125956
    [No Abstract]   [Full Text] [Related]  

  • 23. Diphtheria in Estonia, 1991-1996.
    Jõgiste A; Ching P; Trei T; Kreysler J
    J Infect Dis; 2000 Feb; 181 Suppl 1():S65-8. PubMed ID: 10657193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The return of diphtheria in Europe. Is the French population protected?].
    Rey M; Vincent-Ballereau F; Patey O
    Bull Acad Natl Med; 1997 Jan; 181(1):93-100; discussion 100-2. PubMed ID: 9162517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
    Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemic diphtheria in Belarus, 1992-1997.
    Filonov VP; Zakharenko DF; Vitek CR; Romanovsky AA; Zhukovski VG
    J Infect Dis; 2000 Feb; 181 Suppl 1():S41-6. PubMed ID: 10657189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological features of an outbreak of diphtheria and its control with diphtheria toxoid immunization.
    Youwang Y; Jianming D; Yong X; Pong Z
    Int J Epidemiol; 1992 Aug; 21(4):807-11. PubMed ID: 1521987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diphtheria in Latvia, 1986-1996.
    Griskevica A; Ching P; Russo G; Kreysler J
    J Infect Dis; 2000 Feb; 181 Suppl 1():S60-4. PubMed ID: 10657192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diphtheria antitoxin level 2 years after booster vaccination].
    Nicolay U; Girgsdies OE; Banzhoff A; Hundt E; Kondler-Budde R; Lober R; Hainz R; Jilg W
    Wien Med Wochenschr; 2000; 150(22):435-9. PubMed ID: 11191952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diphtheria immunity in adults in Berlin].
    Neifer S; Siebert B; Huzly D
    Dtsch Med Wochenschr; 1996 Apr; 121(14):460-1. PubMed ID: 8665823
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemic investigation of diphtheria, Republic of Kazakhstan, 1990-1996.
    Kembabanova G; Askarova J; Ivanova R; Deshevoi S; Vitek C; McNabb SJ
    J Infect Dis; 2000 Feb; 181 Suppl 1():S94-7. PubMed ID: 10657198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune response to booster vaccination against diphtheria toxin at age 18-21 years.
    Nahum E; Lerman Y; Cohen D; Salpon R; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):600-3. PubMed ID: 8045740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of vaccination coverage among adults 30-49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995.
    Lewis LS; Hardy I; Strebel P; Tyshchenko DK; Sevalnyev A; Kozlova I
    J Infect Dis; 2000 Feb; 181 Suppl 1():S232-6. PubMed ID: 10657220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
    Campbell JD; Edelman R; King JC; Papa T; Ryall R; Rennels MB
    J Infect Dis; 2002 Dec; 186(12):1848-51. PubMed ID: 12447774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.
    Danilova E; Shiryayev A; Skogen V; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Feb; 23(12):1446-50. PubMed ID: 15670879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to diphtheria booster vaccine in the Baltic states.
    Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
    J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A historical profile of diphtheria in Iran during the 19th and 20th centuries.
    Azizi MH; Bahadori M; Raees-Jalali GA
    Arch Iran Med; 2012 Mar; 15(3):181-6. PubMed ID: 22369311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity against diphtheria and tetanus in the adult Polish population].
    Walory J; Grzesiowski P; Hryniewicz W
    Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.
    Sutter RW; Hardy IR; Kozlova IA; Tchoudnaia LM; Gluskevich TG; Marievsky V; Deforest A; Wharton M
    J Infect Dis; 2000 Feb; 181 Suppl 1():S197-202. PubMed ID: 10657214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.